Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,950
+50 (0.39%)
At close: Aug 13, 2025, 3:30 PM KST
-15.14%
Market Cap 232.90B
Revenue (ttm) 272.12B
Net Income (ttm) 11.34B
Shares Out 17.97M
EPS (ttm) 631.29
PE Ratio 20.53
Forward PE n/a
Dividend 150.00 (1.16%)
Ex-Dividend Date Dec 27, 2024
Volume 18,209
Average Volume 26,333
Open 12,910
Previous Close 12,900
Day's Range 12,860 - 13,070
52-Week Range 9,540 - 15,500
Beta 0.51
RSI 42.19
Earnings Date Aug 13, 2025

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 670
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.